Omayma Elshafie

Tumour Induced Osteomalacia: Rapid Clinical and Biochemical Control Using Octreotide

Omayma Elshafie, Ali Al Magbali & Nicholas Woodhouse · Journal of Advances in Medicine and Medical Research · 2020

Aims: To assess the effects of short acting octreotide on the Fibroblast Growth Factor-23 levels and the clinical outcome in a bedridden patient with Tumour Induced Osteomalacia. Presentation of the Case: A 40-year old female, presented with a 16-year history of progressive weakn...

Open access Research Article 10.9734/jammr/2020/v32i2330717

ACTH Dependent Cushing’s Syndrome: A 72-Hour Trial of Octreotide will Identify Patients with Pituitary Dependent and Ectopic ACTH Overproduction

Omayma Elshafie & Nicholas Woodhouse · Journal of Advances in Medicine and Medical Research · 2020

Aims: To determine whether the use of an octreotide suppression test will reliably distinguish pituitary from ectopic ACTH overproduction.  Somatostatin receptors are expressed in NETs, but are downgraded in the pituitary as the result of hypercortisolaemia. Octreotide should the...

Open access Research Article 10.9734/jammr/2020/v32i1330554

Cushing’s Disease and High Dose Cabergoline Monotherapy: Rapid and Sustained Clinical and Biochemical Improvement, with Reversal of Diabetes, Hypertension and Infertility

Omayma Elshafie, Nagi Hashim & N. Nicholas Woodhouse · Journal of Advances in Medicine and Medical Research · 2015

Aims: To assess the effects of high dose long term cabergoline monotherapy in a patient with Cushing's disease refusing any form of surgical intervention. Presentation of the Case: A 32-year-old Omani female with hypertension, diabetes mellitus and secondary infertility of 10 yea...

Open access Research Article 10.9734/BJMMR/2015/18691